🇺🇸 FDA
Patent

US 6420522

Inhibitors of interleukin-1&bgr; converting enzyme

expired A61KA61K38/00

Quick answer

US patent 6420522 (Inhibitors of interleukin-1&bgr; converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00